San Francisco, CA, December 22, 2020 – Following recent FDA approval of the first two COVID-19 vaccines, GYANT (acq. by Fabric), the AI-powered virtual assistant company, today announced that its vaccine care navigation tool, GYANT Vaccine, has continued to gain traction since its launch in October. The solution is being deployed by numerous health systems, including CHRISTUS Health, Hackensack Meridian Health, MLK Community Healthcare, and Edward-Elmhurst Health, to facilitate the pre- and post-vaccine process in the weeks and months ahead.
With the Pfizer vaccine FDA approved and already being distributed, and Moderna’s vaccine recently granted Emergency Use Authorization, health systems are looking to virtual assistants to build an infrastructure to efficiently manage each stage of rollout. GYANT Vaccine virtually guides patients through the entire pre- and post-vaccination process, from screening to scheduling and proactive follow-ups, to alert patients about eligibility and monitor potential side effects. The solution helps health systems pre-qualify individuals and facilitate deployment in direct alignment with phased or prioritized availability. Moreover, it adapts to each provider’s changing requirements over the course of the vaccine rollout.
As vaccines are approved and production and distribution increase, states will continue to update vaccination policies and procedures. Health systems are thinking ahead by incorporating GYANT’s automated patient education and care navigation to minimize communication workloads, administrative overhead, and keep their providers focused on fighting the pandemic.
“Since vaccine approval, we’ve had strong traction amongst the nation’s leading health systems,” said Stefan Behrens, co-founder and CEO, GYANT. “Patients are eager to reach the other side of the pandemic and intend to get vaccinated as soon as possible. Health systems recognize and are beginning to experience the forthcoming onslaught of patient inquiries about vaccines. We are proud to help manage this overwhelming demand, freeing provider time for meaningful care and streamlining vaccine communication.”
“Putting the patient experience at the forefront of our deployment strategy has been a priority,” said Cheryl Eck, Associate Vice President Strategy & Planning at Edward-Elmhurst Health. “GYANT Vaccine empowers patients to get the information they need to understand more about the vaccine and its rollout.”
About Fabric
Fabric is a health tech company that powers healthcare providers to move faster, work smarter, and deliver better care through its care enablement system. The system offers three solutions: In-Person Care Suite, Virtual Care Suite, and Engagement Suite. Leveraging conversational AI and intelligent adaptive interviews, Fabric unifies virtual and in-person care across intake, triage, routing, and treatment while automating workflows for staff. Built by a team of physicians and clinical informaticists, Fabric protocols uphold excellence in care quality while offering omnichannel access for patients. The results enable clinicians to work 2-10 times faster (dependent on setting), decrease call center volume by 15%, and increase utilization of unfilled visit blocks. Some of Fabric’s customers include Luminis Health, OSF HealthCare, MUSC Health, and Intermountain. Fabric is backed by Thrive Capital, GV (Google Ventures), Salesforce Ventures, Vast Ventures, BoxGroup, and Atento Capital.